NL-OMON43556
Recruiting
Not Applicable
Assessment of Bone Material Strength by Microindentation in vivo after Fracture or Surgery-related Immobilization - BMS after Immobilization
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 42
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age above 50 years
- •Recent fracture of the ankle or calcaneus or arthrodesis surgery of the foot
- •Requirement of \>\= 6 weeks immobilization after a recently sustained fracture of the ankle or calcaneus or arthrodesis surgery of the foot
Exclusion Criteria
- •Metabolic bone disease other than osteoporosis
- •Active infection of the measurement site
- •Recent fracture of the tibia
- •Untreated endocrine disease, including hypogonadism
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Assessment of Bone Material Strength by Microindentation in vivo in Patients with Acromegalybone mechanical propertiesvertebral fracture1002111210017322NL-OMON40686Endocrinologie70
Active, not recruiting
Phase 1
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and PlaceboOsteoporosis is a systemic skeletal disorder characterized by low bone mass and micro-architectural deterioration of bone tissue leading to enhanced bone fragility and susceptibility to fracture. Postmenopausal women with a diagnosis of osteopenia (T score between –2.5 and –1.0 based on the World Health Organization classification) may also be at risk of fracture.MedDRA version: 7.0 Level: PT Classification code 10031285EUCTR2005-003033-41-GBProcter & Gamble Technical Centres Limited156
Active, not recruiting
Not Applicable
A Non-invasive Evaluation of Bone Microarchitecture Modification in Osteopenic Postmenopausal Women by 3D Peripheral Quantitative Computed Tomography: A 12 Month, Multicenter, Double-blind, Randomized, Parallel Group Study Comparing Weekly Oral Risedronate 35 mg and PlaceboEUCTR2005-003033-41-DEProcter & Gamble Technical Centres Limited156
Completed
Phase 4
Prospective evaluation of bone strength, physical activity, falls, subsequent fractures and mortality in patients presenting with a recent clinical fracture.loss of bone mass1001329610017322NL-OMON41637Viecuri Medisch Centrum voor Noord-Limburg500
Recruiting
Not Applicable
Evaluation of bone mineral density and bone metabolism during treatment with the januskinaseinhibitor upadacitinib in patients with rheumatoid arthritisDRKS00021182Campus Kerckhoff der Jusuts-Liebig-Universität Gießen, Abteilung für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin60